In addition to its action on glycemic control through the decrease in hepatic glucose production and increasing the sensitivity of peripheral cells to insulin, a number of studies have shown that metformin is beneficial in reducing diabetes associated vascular risk by inhibition of glycation process and the intermediate of AGEs such as MG [49, 50]. Here, INS is linked to diabetes mellitus.